PinnyPeptide

Matrixyl vs PTD-DBM

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

Matrixyl

Cosmetic

Palmitoyl pentapeptide that signals fibroblasts to rebuild collagen and elastin.

Peptide B

PTD-DBM

Cosmetic

Wnt-activating peptide that blocks CXXC5 — investigational topical hair-regrowth agent.

Typical vial

10 mg

Typical dose

3-5% topical concentration mcg

Half-life

Topical (residence time in stratum corneum)

FDA status

Cosmetic ingredient (not regulated as a drug).

Typical vial

5 mg

Typical dose

Topical formulation-dependent mcg

Half-life

Variable; topical residence-time dependent

FDA status

Not FDA approved.

Matrixyl effects

  • Stimulates dermal collagen I, III, and IV synthesis
  • Increases fibronectin production
  • Increases hyaluronic acid synthesis
  • Reduces fine-line and wrinkle depth over 8-12 weeks
  • Improves skin roughness and dermal thickness

PTD-DBM effects

  • Blocks CXXC5-Dvl interaction in hair follicles
  • Restores Wnt/β-catenin signaling
  • Promotes anagen (growth) phase reactivation
  • Synergistic with valproic acid in preclinical models
  • Investigational topical hair-regrowth agent

Matrixyl side effects

  • Topical: very low rate of irritation or sensitization
  • Occasional contact dermatitis
  • Not formulated or tested for injection

PTD-DBM side effects

  • Limited human safety data
  • Theoretical: off-target Wnt activation in non-follicle tissues
  • Possible scalp irritation with topical use
  • Long-term safety in chronic use unstudied

Matrixyl dosing ranges

Topical anti-aging (cosmetic)

3-5% w/w in topical formulation · Once or twice daily · 8-12 weeks minimum for visible results

PTD-DBM dosing ranges

Topical hair regrowth research

Variable per formulation · Daily topical application to scalp · 12-24 weeks minimum for visible results

Full Matrixyl guide → Full PTD-DBM guide →

Matrixyl vs PTD-DBM — common questions

What is the difference between Matrixyl and PTD-DBM?

Matrixyl: Palmitoyl pentapeptide that signals fibroblasts to rebuild collagen and elastin. Typical dose 3-5% topical concentration mcg. PTD-DBM: Wnt-activating peptide that blocks CXXC5 — investigational topical hair-regrowth agent. Typical dose Topical formulation-dependent mcg. Both fall under the Cosmetic category.

Can you stack Matrixyl and PTD-DBM?

Stacking Matrixyl with PTD-DBM is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, Matrixyl or PTD-DBM?

Matrixyl is typically dosed: Once or twice daily for Topical anti-aging (cosmetic). PTD-DBM is typically dosed: Daily topical application to scalp for Topical hair regrowth research.

Are Matrixyl and PTD-DBM FDA approved?

Matrixyl: Cosmetic ingredient (not regulated as a drug). PTD-DBM: Not FDA approved.

Related peptide comparisons

ghk-cu vs matrixylmatrixyl vs melanotan-iimatrixyl vs pal-ghkmatrixyl vs snap-8ghk-cu vs ptd-dbmmelanotan-ii vs ptd-dbm

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free